Literature DB >> 2990780

Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.

A Raedler, S Fraenkel, G Klose, H G Thiele.   

Abstract

Elevated numbers of peripheral T cells expressing the activation associated antigen T9 are found in patients with active Crohn's disease. Expression of T9 is found to be correlated to the activity of the disease. However the presence of activated peripheral T cells is not restricted to Crohn's disease, but could also be found in other maladies with a supposed involvement of the immune system, e.g. ulcerative colitis, sarcoidosis, connective tissue disease and after organ transplantation. Significant elevation of the number of activated T cells could not be detected in cases of viral or bacterial enteritis and coeliac disease. Analysing the subset of T9 positive T cells with regard to the expression of Fc alpha receptors, a significantly increased number of Fc alpha receptor positive cells, within the subset of T9 positive cells in the peripheral blood of patients with Crohn's disease and ulcerative colitis was found, which could not be demonstrated in the case of other diseases analysed in this study. Thus the T9+ Fc alpha receptor +T cell subset may be considered to be pathognomonic for inflammatory bowel diseases. Analysis of the regulatory properties of T9 positive cells, with regard to the immunoglobulin isotype secretion in a pokeweed mitogen stimulated autologeous B cell assay, suggests that peripheral T9 positive T cells are involved in the suppression of IgA synthesis or secretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990780      PMCID: PMC1577222     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Studies on Crohn's disease. II. Immunoglobulin-containing cells in the terminal ileum.

Authors:  S Persson; D Danielsson
Journal:  Acta Chir Scand       Date:  1973

2.  Immunohistochemical characterization of local immunoglobulin formation in Crohn's disease of the ileum.

Authors:  K Baklien; P Brandtzaeg
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

3.  Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.

Authors:  C Andre; L Descos; P Landais; J Fermanian
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

4.  IgA-specific helper activity of T alpha cells in human peripheral blood.

Authors:  M Endoh; H Sakai; Y Nomoto; Y Tomino; H Kaneshige
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

5.  Alteration in T lymphocyte subpopulations in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

6.  Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells.

Authors:  J W Goding; G F Burns
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Peripheral blood and mesenteric lymph node lymphocytes in Crohn's disease.

Authors:  E R Richens; C M Thorp; P W Bland; K R Gough
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

9.  Covert suppressor T cells in Crohn's disease.

Authors:  C O Elson; A S Graeff; S P James; W Strober
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

10.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  11 in total

1.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.

Authors:  L S Toy; X Y Yio; A Lin; S Honig; L Mayer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

4.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

5.  CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.

Authors:  A M Westendorf; M Templin; R Geffers; S Deppenmeier; A D Gruber; M Probst-Kepper; W Hansen; R S Liblau; F Gunzer; D Bruder; J Buer
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  Phenotype and functional properties of Vicia villosa agglutinin (VVA) binding T cells in patients with Crohn's disease: detection of contrasuppressor activity in patients lacking extra-intestinal manifestations, abscesses and fistulas.

Authors:  A Raedler; H J Lenz; K Sandgren; A de Weerth; S Enversen; S Schreiber; H G Thiele; H Greten
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 7.  Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

Authors:  M J Weldon; J D Maxwell
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

8.  Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  S Schreiber; A Raedler; A R Conn; J L Rombeau; R P MacDermott
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

9.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry.

Authors:  G A Neil; R W Summers; B A Cheyne; C Carpenter; W L Huang; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.